Mavyret, Zepatier, or Vosevi have resulted in rare instances of worsening liver function or liver failure when used to treat Hepatitis C in patients with moderate to severe liver impairment, as indicated in reports issued to the FDA. According to the FDA, each of ...
from Google Alert - health https://ift.tt/2ZCdXLg
via IFTTT
0 comments:
Post a Comment